Cargando…
How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience
BACKGROUND: The Italian Sarcoma Group (ISG) is a nonprofit group of professionals established in 1997 aimed to improve the quality of care and promote the independent research in sarcomas. The increased regulatory requirements, the chance to increase the number of trials with other cooperative group...
Autores principales: | Marchesi, Emanuela, Cagnazzo, Celeste, Quattrini, Irene, Leopardi, Martina Piccinni, Villa, Chiara, Grignani, Giovanni, D’Ambrosio, Lorenzo, Stacchiotti, Silvia, Casali, Paolo Giovanni, Picci, Piero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329913/ https://www.ncbi.nlm.nih.gov/pubmed/28261443 http://dx.doi.org/10.1186/s13569-017-0068-4 |
Ejemplares similares
-
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group
por: Palmerini, Emanuela, et al.
Publicado: (2021) -
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series
por: Palmerini, Emanuela, et al.
Publicado: (2020) -
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis
por: Palmerini, Emanuela, et al.
Publicado: (2022) -
Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions
por: Merlini, Alessandra, et al.
Publicado: (2023) -
Osteosarcoma (Osteogenic sarcoma)
por: Picci, Piero
Publicado: (2007)